Latest News
Ensysce Biosciences, Inc.
- Ensysce Biosciences participates in Family Office Summit, Dubai
- Ensysce Biosciences Initiated at Overweight by Cantor Fitzgerald
- Ensysce Biosciences (ENSC) Slips 2.99% to $0.50 as Micro-Cap Biotech Tests Lower Support - IV Expansion Alert
- Ensysce Biosciences Closes Cy Biopharma Acquisition, Raises $21.5 Million in Private Placement
- Ensysce Biosciences, Inc. Stock Price Prediction: Today, Tomorrow, Next Week (ENSC)
- Ensysce Biosciences (ENSC) Edges Higher: Shares Gain 2.19% to $0.44 - Growth ETF
- Ensysce Biosciences (ENSC) Edges Higher: Shares Gain 2.19% to $0.44 - CTA Positioning
- ENSC News | ENSYSCE BIOSCIENCES INC (NASDAQ:ENSC)
- Ensysce submits Phase 2a protocol for CRPS treatment CY200
Headlines from the last 30 days, linking to the original publishers. See all market news →